Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
and potential for combination in preclinical models
At 5 μM it directly inhibits DUB activity of USP9x
Smiles: NCC(CS(O)(=O)=O)C1C=CC(Cl)=CC=1
MLN8237 is currently in Phase II study for treatment of patients with ovarian
32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24
MGCD0103 - CAS# 726169-73-9 Catalog No.:M6555-10 and potential for combination inMGCD0103, also known as Mocetinostat, CAS No. 726169 73 9, is a rationally designed, orally available, Class 1 selective, small molecule, 2 aminobenzamide HDAC inhibitor with potential antineoplastic activity. MGCD0103 binds to and inhibits Class 1 isoforms of HDAC, specifically HDAC 1, 2 and 3, which may result in epigenetic changes in tumor cells and so tumor cell death; although the exact mechanism has yet to be defined, tumor cell death may occur
US$ 260.00
US$ 116.00